A phase II study of outpatient chemotherapy with cisplatin, 5-fluorouracil, and leucovorin in nasopharyngeal carcinoma
- 15 January 1994
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for locally advanced head and neck cancer: a clinical and pharmacologic analysis.Journal of Clinical Oncology, 1990
- Continuous Infusion High-Dose Leucovorin with 5-Fluorouracil and Cisplatin for Untreated Stage IV Carcinoma of the Head and NeckAnnals of Internal Medicine, 1990
- Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.Journal of Clinical Oncology, 1989
- A phase I clinical trial of combined fluoropyrimidines with leucovorin in a 14-day infusion. Demonstration of biochemical modulationCancer, 1989
- Carcinoma of the nasopharynx: An analysis of 91 cases and a comparison of differing treatment approachesCancer, 1986
- Nasopharyngeal cancer: Study III. A review of 1206 patients treated with combined modalitiesInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatinCancer, 1985
- Superior clinical response and survival rates with initial bolus of cisplatin and 120 hour infusion of 5-fluorouracil before definitive therapy for locally advanced head and neck cancerThe American Journal of Surgery, 1984
- Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neckCancer, 1984
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958